Henry Kahwaty

Dr. Kahwaty also has completed analyses of intellectual property damages and the economic impact of changes in government policy. Dr. Kahwaty’s policy work includes the analysis of issues in healthcare, including the costs associated with changes in Medicare, Medicaid, and the availability of generic drugs and biologic medicines. He has also worked on small business issues.

Dr. Kahwaty has presented analyses to the Antitrust Division of the US Department of Justice (DOJ), Federal Trade Commission (FTC), Directorate-General for Competition of the European Commission (EC), Federal Energy Regulatory Commission, Centers for Medicare & Medicaid Services, Congressional Budget Office, Congressional Committee Staff, Medicare Payment Advisory Commission, and  Small Business Administration.

Dr. Kahwaty has testified on cases during FTC, Canadian Competition Tribunal, and EC hearings. He prepared two reports on competition in banking for the Irish Competition Authority and assisted the Irish Competition Authority with its study of competition in the insurance industry.

Dr. Kahwaty started his career as an economist with the Antitrust Division of the DOJ. At the Antitrust Division, he specialized in market power analysis for merger and monopolization cases with a focus on the computer software, banking, manufacturing, and defense industries. He spent fifteen years as a senior economist, principal, and director with LECG working out of LECG’s offices in Washington and London. He received his PhD in economics from the University of Pennsylvania in 1991 and was recognized in the 2011 and 2013–2019 editions of The International Who’s Who of Competition Lawyers & Economists.